Sabatolimab Plus Hypomethylating Agents (Hmas) In Patients (Pts) With High-/Very High-Risk Myelodysplastic Syndrome (Hr/Vhr-Mds) And Acute Myeloid Leukemia (Aml): Subgroup Analysis Of A Phase 1 Study
Sabatolimab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Sabatolimab Plus Hypomethylating Agents (Hmas) In Patients (Pts) With High-/Very High-Risk Myelodysplastic Syndrome (Hr/Vhr-Mds) And Acute Myeloid Leukemia (Aml): Subgroup Analysis Of A Phase 1 Study ### Output: Sabatolimab